Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer
NCT: NCT06952920 · RECRUITING
Brief Summary
This study aims to elucidate the therapeutic efficacy of electroacupuncture in managing chemotherapy-induced gastrointestinal symptom clusters through clinical research. Building upon this foundation, multi-omics analyses will be conducted to investigate the regulatory effects and underlying mechanisms of electroacupuncture on gastrointestinal symptoms. Ultimately, genomic studies will be performed to further clarify the key targets of electroacupuncture intervention, thereby providing high-level evidence-based medical support and theoretical foundations for optimizing electroacupuncture strategies in addressing chemotherapy-induced gastrointestinal symptoms in patients with cancer.
Frequently Asked Questions
What is Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer?
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer is a clinical trial registered under NCT06952920. Current status: RECRUITING.
What is the status of NCT06952920?
The current status of NCT06952920 (Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer) is: RECRUITING.
When did Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer start?
Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer started on 2025-08-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.